Brief: Core Lab Posts Q1 EPS Of $0.04

Core Laboratories

27/04/2022 23:07

April 27 (Reuters) - Core Laboratories NV  CLB.N :
    * CORE LAB REPORTS FIRST QUARTER 2022 RESULTS FROM
CONTINUING
OPERATIONS
    * Q1 REVENUE OF $115.3 MILLION; UP 6% YEAR-OVER-YEAR
    * Q1 GAAP LOSS PER SHARE $0.04
    * QTRLY EPS, EX-ITEMS, $0.08
    * ON-GOING GEOPOLITICAL CONFLICT BETWEEN RUSSIA AND UKRAINE
IS
ADVERSELY IMPACTING SERVICE REVENUE AND PRODUCT SALES
    * COMPLETION PRODUCT SALES DELIVERED THROUGH CORE'S
PRODUCTION
ENHANCEMENT SEGMENT DIRECTLY INTO UKRAINE HAVE BEEN SUSPENDED
    * HAS HISTORICALLY GENERATED APPROXIMATELY 5% TO 8% OF ITS
TOTAL
REVENUE FROM RUSSIA, UKRAINE AND SOUTHEASTERN EUROPEAN REGION
    * PROJECTS Q2 2022 REVENUE TO RANGE FROM $119MLN TO $125
MILLION
    * EPS FOR Q2 OF 2022 IS EXPECTED TO BE $0.12 TO $0.16
    * Q1 EARNINGS PER SHARE VIEW $0.09, REVENUE VIEW $116.1
MILLION --
REFINITIV IBES DATA
    * Q2 EARNINGS PER SHARE VIEW $0.16, REVENUE VIEW $124.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPn8Wx8Fwa 
Further company coverage:  CLB.N 

 ((Reuters.Briefs@thomsonreuters.com;))